LSL Videos

PITCHING AND FUNDRAISING IN THE NEW NORM

  • Pitching And Fundraising In The New Norm

    Raising money for a startup biopharma is a task that never ends, even during a pandemic. This is good. Because while some industries experienced significant financial collapse last year, biopharma was perfectly positioned to provide COVID-19 solutions, which it has at an unprecedented pace.

PREPARING FOR A VIRTUAL J.P. MORGAN HEALTHCARE CONFERENCE (JPM)

  • Preparing For A Virtual J.P. Morgan Healthcare Conference (JPM)

    Unfortunately, like so many in-person events negatively impacted by COVID-19 last year, the 2021 JPM conference will be 100% virtual. So, we thought it would be interesting to have a discussion with three biopharmaceutical executives about how they are preparing for this unique JPM and how those preparations are different than what they’ve done in the past.

MANUFACTURING AND SUPPLY CHAIN RISK MITIGATION STRATEGIES AMIDST COVID-19

TACKLING HR IN BIOPHARMA DURING A PANDEMIC

ACCELERATING YOUR BIOPHARMA STARTUP'S PATH TO THE CLINIC

  • Accelerating Your Biopharma Startup’s Path To The Clinic

    Pamela Contag, Ph.D., cofounder and CEO of BioEclipse Therapeutics, and Dara Lockert, founder and executive director of Spannerwerks, a consultancy, share best practices and lessons learned during the drive to get a biopharma startup to the clinic as quickly as possible. 

PREPARING FOR THE NEW BIOMANUFACTURING FRONTIER: A FIRESIDE CHAT WITH FLUGEN'S ANDY SKIBO

BIOPHARMA AND THE MANAGEMENT OF WALL ST. DURING A PANDEMIC

  • Biopharma And The Management Of Wall St. During A Pandemic

    The volatility of the U.S. stock market in the first half of 2020 has even the heartiest investor queasy. But how about the leaders of such publicly traded companies? We conduct a virtual roundtable with three CEOs of publicly traded biopharmaceutical companies to learn how they are leading their organizations while also managing the expectations of Wall Street during the COVID-19 pandemic.

AN INTERVIEW WITH ROBERT HARIRI, M.D., PH.D., CEO AND FOUNDER OF CELULARITY

VIRTUAL ROUNDTABLES

During the COVID-19 pandemic of 2020, Life Science Leader decided to engage with some of our executive-level readers via Zoom conference calls. These virtual roundtables were hosted by our Chief Editor Rob Wright and then broken up into shorter clips based on specific questions or topics discussed during the full-length call.